IGF-1 and Bone Loss in Women With Anorexia Nervosa.
Phase of Trial: Phase IV
Latest Information Update: 17 Jul 2017
At a glance
- Drugs Mecasermin (Primary) ; Risedronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 19 Jan 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.
- 08 Feb 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017 as reported by ClinicalTrials.gov record.
- 07 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.